Cocrystal Pharma Announces Presentation of Preclinical Characterization Data of CC-42344 at the 6th ISIRV-AVG Conference - Company’s novel, broad spectrum influenza antivirals specifically designed to be effective against all significant A strains of the influenza virus -  - CC-43244, Company’s lead molecule has...